The Clinigen Group Plc, a specialty pharmaceutical company, successfully raised £135 million in late April to finance its £225 million acquisition of Idis Group Holdings Ltd, a supplier of unlicensed medicines to the hospital market. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
